Pierre J. Dilda
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO-10-27.
Journal: Journal of cachexia, sarcopenia and muscle
Published: March 24, 2025
Neuroprotective Effect of Mas Activation by BIO101 in Vincristine-Induced Small Fiber Neuropathy.
Journal: Journal of the peripheral nervous system : JPNS
Published: February 20, 2025
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.
Journal: Journal of cachexia, sarcopenia and muscle
Published: May 28, 2024
RAR Inhibitors Display Photo-Protective and Anti-Inflammatory Effects in A2E Stimulated RPE Cells In Vitro through Non-Specific Modulation of PPAR or RXR Transactivation.
Journal: International journal of molecular sciences
Published: December 20, 2023
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.
Journal: EClinicalMedicine
Published: July 10, 2023
Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD).
Journal: International journal of molecular sciences
Published: January 02, 2023
BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice.
Journal: Journal of cachexia, sarcopenia and muscle
Published: November 16, 2022
A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.
Journal: Journal of cachexia, sarcopenia and muscle
Published: May 13, 2022
Structural analysis of unstable norbixin isomers guided by pure shift nuclear magnetic resonance.
Journal: Magnetic resonance in chemistry : MRC
Published: December 17, 2021
A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality.
Journal: Emerging microbes & infections
Published: November 16, 2021
20-Hydroxyecdysone activates the protective arm of the RAAS via the MAS receptor.
Journal: Journal of molecular endocrinology
Published: October 01, 2021
Ecdysteroid metabolism in mammals: The fate of ingested 20-hydroxyecdysone in mice and rats.
Journal: The Journal of steroid biochemistry and molecular biology
Published: January 29, 2021
Last Updated: 09/26/2026